1. Home
  2. ABVE vs ELTX Comparison

ABVE vs ELTX Comparison

Compare ABVE & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABVE
  • ELTX
  • Stock Information
  • Founded
  • ABVE 2019
  • ELTX 2011
  • Country
  • ABVE Canada
  • ELTX United States
  • Employees
  • ABVE N/A
  • ELTX N/A
  • Industry
  • ABVE Packaged Foods
  • ELTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • ABVE Consumer Staples
  • ELTX Health Care
  • Exchange
  • ABVE Nasdaq
  • ELTX Nasdaq
  • Market Cap
  • ABVE 35.9M
  • ELTX 121.7M
  • IPO Year
  • ABVE N/A
  • ELTX N/A
  • Fundamental
  • Price
  • ABVE $3.63
  • ELTX $8.09
  • Analyst Decision
  • ABVE
  • ELTX Strong Buy
  • Analyst Count
  • ABVE 0
  • ELTX 2
  • Target Price
  • ABVE N/A
  • ELTX $9.50
  • AVG Volume (30 Days)
  • ABVE 34.9M
  • ELTX 48.3K
  • Earning Date
  • ABVE 02-15-2025
  • ELTX 08-12-2025
  • Dividend Yield
  • ABVE N/A
  • ELTX N/A
  • EPS Growth
  • ABVE N/A
  • ELTX N/A
  • EPS
  • ABVE N/A
  • ELTX N/A
  • Revenue
  • ABVE $213,446,206.00
  • ELTX N/A
  • Revenue This Year
  • ABVE N/A
  • ELTX N/A
  • Revenue Next Year
  • ABVE N/A
  • ELTX N/A
  • P/E Ratio
  • ABVE N/A
  • ELTX N/A
  • Revenue Growth
  • ABVE N/A
  • ELTX N/A
  • 52 Week Low
  • ABVE $0.25
  • ELTX $3.70
  • 52 Week High
  • ABVE $4.40
  • ELTX $9.99
  • Technical
  • Relative Strength Index (RSI)
  • ABVE N/A
  • ELTX 62.14
  • Support Level
  • ABVE N/A
  • ELTX $7.76
  • Resistance Level
  • ABVE N/A
  • ELTX $8.94
  • Average True Range (ATR)
  • ABVE 0.00
  • ELTX 0.37
  • MACD
  • ABVE 0.00
  • ELTX -0.03
  • Stochastic Oscillator
  • ABVE 0.00
  • ELTX 51.09

About ABVE Above Food Ingredients Inc. Common Stock

Above Food Ingredients Inc is a differentiated, regenerative ingredient company. Its products are made with real nutritious, flavorful ingredients and delivered with transparency. Its vision is to create a healthier world one seed, one field, and one bite at a time. With a robust chain of custody of plant proteins, enabled by scaled operations and infrastructure in primary agriculture and processing, and proprietary seed development capabilities that leverage the power of artificial intelligence driven genomics. The company delivers nutritious foods to businesses and consumers with traceability and sustainability. Above Food's consumer products and brands are available in grocers across Canada and the United States.

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.

Share on Social Networks: